Houlihan Lokey is pleased to announce the signing of a definitive agreement by Mitsubishi Chemical Corporation (MCC) to acquire Gelest, Inc., and its affiliated entities (Gelest) from New Mountain Capital, L.L.C. (NMC). The closing of the transaction is expected in 2020, pending customary regulatory reviews and approvals.
MCC is Japan's largest chemical company, offering a wide variety of performance products and industrial chemicals for a broad range of end markets, including healthcare/medical, electronics, food, automotive/aircraft, energy, and packaging and labels, among others. MCC is headquartered in Tokyo, Japan, and has over 40,000 employees in more than 30 countries around the world.
Gelest is an innovative manufacturer and supplier of silicones, organosilanes, metal-organics, and specialty monomers for advanced technology end markets, including medical devices, life sciences, microelectronics, and personal care. Gelest helps customers succeed by assisting them to develop and supply the chemistry to solve their most challenging materials science problems and enable their new product technology. Gelest was founded in 1991 and is headquartered in Morrisville, Pennsylvania.
NMC is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with more than $20 billion in assets under management. NMC seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies.
Houlihan Lokey served as the exclusive buyside advisor to MCC. This transaction leveraged Houlihan Lokey's deep knowledge and understanding of the global specialty chemicals industry and highlights the firm's cross-border M&A capabilities and robust coverage of Japanese corporate clients.
VIEW ALL TRANSACTIONS